BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 27001343)

  • 1. Hepatocyte nuclear factor 1 beta induces transformation and epithelial-to-mesenchymal transition.
    Matsui A; Fujimoto J; Ishikawa K; Ito E; Goshima N; Watanabe S; Semba K
    FEBS Lett; 2016 Apr; 590(8):1211-21. PubMed ID: 27001343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOXB7 induces STAT3-mediated transformation and lung metastasis in immortalized mammary gland NMuMG cells.
    Azuma K; Sakamoto M; Katayama S; Matsui A; Nakamichi K; Goshima N; Watanabe S; Nakayama J; Semba K
    Genes Cells; 2023 Apr; 28(4):277-287. PubMed ID: 36659836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of retinoic acid receptor alpha (RARA) induces epithelial-to-mesenchymal transition and disruption of mammary acinar structures.
    Doi A; Ishikawa K; Shibata N; Ito E; Fujimoto J; Yamamoto M; Shiga H; Mochizuki H; Kawamura Y; Goshima N; Semba K; Watanabe S
    Mol Oncol; 2015 Feb; 9(2):355-64. PubMed ID: 25300573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
    Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
    Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA interference-based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes.
    Kao J; Pollack JR
    Genes Chromosomes Cancer; 2006 Aug; 45(8):761-9. PubMed ID: 16708353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
    Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
    Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
    Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
    Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer.
    Lee HK; Lee DS; Park JC
    BMC Cancer; 2015 Mar; 15():113. PubMed ID: 25879941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of KRAS promotes the mesenchymal features of basal-type breast cancer.
    Kim RK; Suh Y; Yoo KC; Cui YH; Kim H; Kim MJ; Gyu Kim I; Lee SJ
    Exp Mol Med; 2015 Jan; 47(1):e137. PubMed ID: 25633745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPOCK1 is a novel transforming growth factor-β target gene that regulates lung cancer cell epithelial-mesenchymal transition.
    Miao L; Wang Y; Xia H; Yao C; Cai H; Song Y
    Biochem Biophys Res Commun; 2013 Nov; 440(4):792-7. PubMed ID: 24134845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-Generation Sequencing Approach in Methylation Analysis of HNF1B and GATA4 Genes: Searching for Biomarkers in Ovarian Cancer.
    Bubancova I; Kovarikova H; Laco J; Ruszova E; Dvorak O; Palicka V; Chmelarova M
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of C/EBPalpha expression in periportal hepatoblasts may stimulate biliary cell differentiation through increased Hnf6 and Hnf1b expression.
    Yamasaki H; Sada A; Iwata T; Niwa T; Tomizawa M; Xanthopoulos KG; Koike T; Shiojiri N
    Development; 2006 Nov; 133(21):4233-43. PubMed ID: 17021047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.
    Huber MA; Azoitei N; Baumann B; Grünert S; Sommer A; Pehamberger H; Kraut N; Beug H; Wirth T
    J Clin Invest; 2004 Aug; 114(4):569-81. PubMed ID: 15314694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FoxA1 as a lineage-specific oncogene in luminal type breast cancer.
    Yamaguchi N; Ito E; Azuma S; Honma R; Yanagisawa Y; Nishikawa A; Kawamura M; Imai J; Tatsuta K; Inoue J; Semba K; Watanabe S
    Biochem Biophys Res Commun; 2008 Jan; 365(4):711-7. PubMed ID: 18039470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta.
    Sokol JP; Neil JR; Schiemann BJ; Schiemann WP
    Breast Cancer Res; 2005; 7(5):R844-53. PubMed ID: 16168131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
    Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancer cooperativity as a novel mechanism underlying the transcriptional regulation of E-cadherin during mesenchymal to epithelial transition.
    Alotaibi H; Basilicata MF; Shehwana H; Kosowan T; Schreck I; Braeutigam C; Konu O; Brabletz T; Stemmler MP
    Biochim Biophys Acta; 2015 Jun; 1849(6):731-42. PubMed ID: 25652130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells.
    Park CY; Kim DK; Sheen YY
    Cancer Sci; 2011 Oct; 102(10):1889-96. PubMed ID: 21707864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer.
    Ross-Adams H; Ball S; Lawrenson K; Halim S; Russell R; Wells C; Strand SH; Ørntoft TF; Larson M; Armasu S; Massie CE; Asim M; Mortensen MM; Borre M; Woodfine K; Warren AY; Lamb AD; Kay J; Whitaker H; Ramos-Montoya A; Murrell A; Sørensen KD; Fridley BL; Goode EL; Gayther SA; Masters J; Neal DE; Mills IG
    Oncotarget; 2016 Nov; 7(46):74734-74746. PubMed ID: 27732966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HNF1B-associated clinical phenotypes: the kidney and beyond.
    Bockenhauer D; Jaureguiberry G
    Pediatr Nephrol; 2016 May; 31(5):707-14. PubMed ID: 26160100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.